as household members and other persons who had intimate contact with the child (e.g., relatives and friends) as well as hospital staff directly exposed to his respiratory secretions. Hospital contacts were enumerated by infection control staff. Information on other close contacts was obtained through family interviews. After initial visits to the homes of close contacts to screen for signs and symptoms of diphtheria and to implement preventive measures, identified close contacts were monitored for at least I week by home visits, telephone contacts, and clinic visits.
Laboratory Procedures
During the first 2 weeks of the investigation, pharyngeal swabs obtained for culture of Corynebacterium diphtheriae were inoculated directly onto tellurite agar and Tinsdale's medium at the hospital's laboratory. Thereafter, swabs were transported on Pai slants to the Florida Department of Health and Rehabilitative Services Laboratory in Jacksonville, where they were inoculated onto tellurite agar. Tinsdale's medium, blood agar, and chocolate agar. All isolates suspected to be C. diphtheriae were biochemically characterized and tested for toxigenicity by the method of Elek [10] at the CDC's diphtheria reference laboratory.
Serological Survey for Antibodies to Diphtheria Toxin
Sera from a sample of children < 15 years of age who had been randomly selected for a survey of human immunodeficiency virus (HIV) seroprevalence [11] and who were found to be seronegative for HIV were tested for antibodies to diphtheria toxin by toxin neutralization in VERO cells [12] at St. Christopher's Children's Hospital in Philadelphia. These children had received care at some point during the period from January through August 1990 at a community medical center that predominantly serves indigent patients in Dade County and had had blood submitted to the chemistry laboratory. For each child, information on race and age group (<5 or 5-14 years), but not on vaccination history, was available.
Case Report

Summary of the Case
On 13 January 1990, a previously healthy. 25-month-old. unimmunized boy with a 3-day history of cough and fever presented to the pediatric emergency department at a community hospital in Dade County. Florida. The child was born in the United States of parents who had immigrated from Haiti in 1981. He did not attend day care outside of his home and had no history of travel or disease exposures. At presentation he had a temperature of 39.4°C, pharyngeal erythema, wheezing, stridor, cervical swelling, and cervical lymphadenopathy. A chest radiograph showed subglottic narrowing and bilateral lung hyperinflation. Initial diagnoses were wheezing-associated acute respiratory infection and croup. Despite bronchodilator therapy in the emergency department, respiratory symptoms worsened, and on 14 January the boy required endotracheal intubation. The procedure was uncomplicated, and the epiglottis appeared normal.
By 17 January multiple complications had developed, including anuric renal failure, pneumonia with pleural effusion, transient ventricular tachycardia, and hypertrophic cardiomyopathy (demonstrated by echocardiography). On 18 January, during endotracheal tube replacement, the observation of thick gray pharyngeal and tracheal membranes that bled upon attempted removal led to a presumptive diagnosis of diphtheria. By then, the child had received cefotaxime, trimethoprim-sulfamethoxazole, and oxacillin. After collection of a pharyngeal swab for culture, treatment with intravenous penicillin was started. Diphtheria antitoxin was obtained promptly, but the child developed multiple cardiac dysrhythmias and died before it could be administered. Tonsillar, palatal, epiglottic, and laryngeal membranes were noted at autopsy. Although the culture of the pharyngeal swab obtained before the child's death was negative and postmortem histopathologic examination did not suggest diphtheritic myocarditis, the diagnosis of diphtheria was confirmed on 8 February on the basis of a postmortem epiglottic culture that yielded toxigenic C. diphtheriae of the mitis type.
Epidemiological Investigation
Household and other close contacts. The child had an extended family consisting of relatives and friends who lived in separate households but who typically ate meals together and slept at one another's homes. On 19 January health department staff located 11 close contacts of the child, including his parents and their seven remaining children, who lived in a two-bedroom apartment, and an adult and a child from another household. Although initially apprehensive because of language and cultural barriers, the family eventually enumerated 14 additional close contacts. Of these, 10 children (10 months to 9 years of age) and two adults from a third household were located on 5 February. All 23 contacts who were located had been exposed to the case-patient around the time of his illness. A child and an adult from the third household recently had been in Haiti for 8 months and 2 weeks, respectively, and had returned to Dade County ~6 weeks before the case-patient's illness. The remaining two contacts, including a woman who frequently traveled to Haiti, could not be located. More detailed travel and exposure histories for these two contacts could not be obtained.
For 19 of the 23 contacts located, vaccination histories were verified by vaccination cards or medical records. Five children who had not yet received three doses of diphtheria toxoid, three adults who had not received a dose within the previous 5 years, and two adults and two children whose vaccination histories were unknown were given a dose of diphtheria toxoid. After pharyngeal swabs were obtained for culture, each of the contacts, regardless of vaccination status, was given antimicrobial prophylaxis with either one dose of intramuscular benzathine penicillin (children) or a 10-day course of oral erythromycin (adults). Except for coryza in a 10-month-old infant, all contacts remained asymptomatic.
Final culture results, reported on 2 February, indicated that three contacts (13%) were infected with toxigenic C. diphtheriae of the mitis type: these contacts were siblings of the case-patient and were 2, 4, and 5 years of age, respectively. Two of the three had previously received one dose each of diphtheria toxoid, and one had an unknown vaccination history. Follow-up cultures of pharyngeal swabs obtained both 1 week and 2 weeks after receipt of penicillin were negative.
Hospital contacts. Infection control staff enumerated 94 hospital employees who worked in areas where the casepatient had received care. Pharyngeal cultures were initially recommended for those who may have been exposed to his respiratory secretions. However, because the closeness of contact was not systematically, ascertained and culture media were not readily available, no cultures were performed. Vaccination records indicated that eight (9%) of the 94 employees had most recently received diphtheria toxoid within the previous 5 years. 74 (79%) during the previous 6-10 years, and 12 (13%) more than 10 years earlier. Of the 86 employees in the latter two groups. 72 were given a booster dose of diphtheria toxoid at the employee health clinic and 14 were lost to follow-up. Of the 12 employees who had not received a dose within the previous 10 years, four received erythromycin prophylaxis and eight were lost to follow-up.
Neighborhood contacts. Although the family indicated that the case-patient had had no neighborhood contacts, a limited investigation was conducted because of uncertainty about the reliability of the interviews. On 6 February interviews with six other families who resided in adjacent homes confirmed the family's reports. Of cultures of pharyngeal swabs obtained from 24 persons who were at home during these visits, none were positive for C. diphtheriae.
Contacts of carriers.
The three siblings with positive cultures had no additional close contacts. However, a preliminary report of a suspicious result of a culture for C. diphtheriae in their 7-year-old sibling led to his exclusion from school and to further investigation. Of five teachers and 26 students with whom he had close contact, three teachers who had not received diphtheria toxoid within the previous 5 years and one student in need of the fourth dose of diphtheria and tetanus toxoids and pertussis vaccine (DTP) were vaccinated at school. Of 26 contacts available for cultures, none were infected with C. diphtheriae. Final results of the initial culture and two follow-up cultures from the case-patient's 7-year-old sibling were also negative. 
Discussion
In the United States and other industrialized countries, improved control of diphtheria during the past 50 years and its near elimination in recent decades reflect the remarkable success of childhood vaccination programs. Not only does immunization against diphtheria confer individual protection: vaccination of ≥70% of a population may also provide herd immunity [14. 15] . In addition, as described by Pappenheimer, widespread immunization with diphtheria toxoid may lead to the elimination of circulating toxigenic strains of C. [35] [36] [37] . Low levels of preschool vaccination are also reflected in our serological survey, in which more than 20% of preschool-aged children lacked immunity to diphtheria toxin. Moreover, our results likely underestimate community levels of susceptibility to diphtheria among preschool-aged children because those without access to medical care were not assessed. The higher level of protective immunity among children 5-14 years of age reflects state laws requiring vaccination before school entry. In other recent serological surveys, 20% to >50% of selected adolescents and adults lacked immunity to diphtheria toxin [38] [39] [40] [41] [42] , with particularly low levels among the elderly, possibly due to lack of natural exposure during the vaccine era, low rates of vaccination, and/or waning vaccine-induced immunity [39] .
As was demonstrated by diphtheria outbreaks in Sweden and Denmark in the 1980s [13, 43] , epidemics may occur in unvaccinated population subgroups despite widespread childhood vaccination. As has been mentioned, importation of toxigenic C. diphtheriae from developing countries where diphtheria remains endemic poses a constant threat and has accounted for most cases of diphtheria in recent years in industrialized countries [2, [6] [7] [8] 20] . Although the source of infection was not documented in our investigation, the history of travel to Haiti among contacts of the case-patient and the absence of reported diphtheria in Dade County for more than 20 years suggest importation as a possibility. Because carriage of C. diphtheriae by untreated, asymptomatic persons lasts an average of 10 days [44, 45] , some contacts may have had infections that cleared by the time pharyngeal swabs were obtained for culture. Furthermore, not all contacts were located; those who could not be found included one woman who frequently traveled to Haiti. Studies of the molecular biology of diphtheria suggest that conversion of non toxigenic C. diphtheriae to a toxin-producing strain by lysogenic transfer of the gene coding for toxigenicity could have occurred [4] , but no non toxigenic strains were recovered from contacts.
Recommendations for Prevention and Control of Diphtheria
The need for rapid clinical and public health responses to diphtheria, a potentially fatal but rare disease, prompted us to review the recommendations and underlying rationale for the management of cases, the investigation of contacts, and the institution of preventive measures. On the basis of our review, we developed an algorithm to guide management and investigation of diphtheria (figure I) should suspected or proven cases occur in the future.
Clinical Diagnosis
Because respiratory diphtheria may progress rapidly, a high index of suspicion needs to be maintained. Classical respiratory diphtheria is characterized by insidious onset, membranous pharyngitis with fever, enlarged anterior cervical lymph nodes, and edema of surrounding soft tissue, which gives rise to a "bull neck" appearance [14, 16, 47] . Although not always present, the membrane is typically gray, thick, fibrinous, and firmly adherent. Laryngeal diphtheria is characterized by gradually increasing hoarseness and stridor and most commonly occurs as an extension of pharyngeal involvement in children [14, 47] .
Laboratory Diagnosis
Because the successful isolation of C. diphtheriae depends on rapid inoculation of special culture media, the laboratory should be notified as soon as the diagnosis is suspected. With routinely available throat or nasopharyngeal swabs, samples preferably should be obtained from the membrane (if present) or from beneath its edge. Although nasal diphtheria in the absence of pharyngeal involvement is uncommon, culturing of both nasal and pharyngeal secretions may improve the rate of isolation of C. diphtheriae [5, 51, 52] . Methods for the bacteriologic diagnosis of diphtheria have been described in detail elsewhere [53] [54] [55] . In brief, a confirmatory diagnosis may take several days and requires culture and isolation of the organism, biochemical typing, and toxigenicity testing. In some instances, a presumptive diagnosis may be made within <24 hours on the basis of cellular morphology on a methylene blue-stained smear of growth obtained after incubation on Loeffler or Pai medium [54, 55] . However, microscopic examination of direct-stained or fluorescent antibody-stained smears is generally considered unreliable [46, 53, 54, 56, 57] .
Although not a widely available test, the measurement of antibodies to diphtheria toxin in serum collected before administration of antitoxin may support the diagnosis if the level is nonprotective (<0.01 IU/ml) [50] . This information may be particularly useful when a patient's cultures are negative as a result of prior antimicrobial therapy or for other reasons. [14, [46] [47] [48] (40-50 mg/[kg · d] . with a maximum of 2 g/d) has been recommended [46, 49] until the patient can swallow comfortably, at which point oral erythromycin in four divided doses [46, 49] 
Management
Patients with suspected respiratory diphtheria should be placed in strict isolation and treated on clinical grounds; therapy should not be delayed until bacteriologic confirmation is available [14, 46, 48, 50] . Diphtheria antitoxin-hyperimmune antiserum produced in horses-is the mainstay of therapy.
Because antitoxin neutralizes only circulating toxin that is not yet bound to tissue, prompt administration is critical. Although not a substitute for antitoxin, penicillin or erythromycin should also be administered so that the organism will be eradicated, toxin production terminated, and the likelihood of transmission decreased [14, 46, 47, 49] .
Clinical attention should be directed to signs of airway obstruction, acute systemic toxicity, and toxin-mediated myocarditis and neuritis [14, 58, 59] . Myocarditis may present acutely, with congestive heart failure and circulatory collapse, or more insidiously, with progressive dyspnea, weakness, diminished heart sounds, and gallop rhythm [14, 47] . Electrocardiographic abnormalities, such as T-wave alterations and first-degree heart block, may occur in the absence of clinical signs [47, 59] and progress to severe block. atrioventricular dissociation, and other potentially fatal arrhythmias [58, 59] .
Neurological complications consist primarily of motor loss involving cranial or peripheral nerves [14, 47] . Palatal and pharyngeal paralysis may occur acutely. Oculomotor and ciliary paralysis and, most commonly, lower-extremity peripheral neuritis may manifest 2-8 weeks after the onset of illness. Dysfunction varies from mild weakness to total paralysis and almost always resolves completely.
Mechanical airway obstruction and myocarditis account for most diphtheria-related deaths. The case-fatality rate for respiratory diphtheria has been nearly 10% in the United States in recent decades [60, 61] and was 18% (3/17) in the recent Swedish outbreak [43] .
Identification of Secondary Cases and Carriers
Whenever the diagnosis of diphtheria is strongly suspected, local public-health officials should be notified, and measures to prevent additional cases should be instituted promptly. Infection with C. diphtheriae may result in asymptomatic carriage or disease of varying severity [14, 17] . In view of the short incubation period of diphtheria ( 1-6 days) and the delays encountered in bacteriologic diagnosis, the primary means of detecting cases is to monitor close contacts daily lor at least 7 days [46, 48, 50] . Asymptomatic carriers should also be identified because they may transmit the organism [15, 26, 29, 51, 62] . In addition, finding a carrier among close contacts may support the diagnosis of diphtheria in the absence of bacteriologic confirmation. Although diphtheria toxoid protects against clinical diphtheria and complications, it has not been associated with the prevention of either infection or carriage [14, 17, 25, 29, 63, 64] . Thus, in the search for cases and carriers, nasal and pharyngeal swabs should be obtained from all close contacts, regardless of vaccination status [46, 48, 50] .
Because the risk of infection is directly related to the closeness and the duration of contact and the intensity of exposure [14-16, 65, 66] , the search lor infected contacts should usually begin in the case-patient's household and be limited to settings in which intimate respiratory or physical contact with the casepatient may have occurred [46, 50] . Reported rates of carriage of toxigenic C. diphtheriae among household contacts of casepatients have ranged from 0 to 25% [6, 9, [24] [25] [26] [27] (table 2) ; the carriage rate was 13% in our investigation. This variation may be due to differences in intensity of exposure, antimicrobial use, timing of cultures, and laboratory techniques. Whereas spread of diphtheria has been reported in institutions for mentally handicapped persons [32, 33] , transmission in modern hospitals in the United States and other developed countries was not demonstrated in studies we reviewed [6, 7, 22, 28, 30, 31] (table 2) . Investigation of casual contacts and of persons in the community without known exposure to diphtheria has generally yielded extremely low figures for carriage rates [5, 7, [21] [22] [23] 34] (table 2) and is not routinely recommended.
Antimicrobial Treatment for Contacts
A single dose of intramuscular penicillin or a 7-to l0-day course of oral erythromycin is recommended for all persons exposed to diphtheria, regardless of vaccination status, as soon as samples are obtained for culture [46, 50] . Whereas the efficacy of postexposure antimicrobial prophylaxis in preventing diphtheria is presumed but not proven, each of these drugs has been shown to eradicate C. diphtheriae from the respiratory tract of carriers [5, 21, 33, 64, [67] [68] [69] . Although available data suggest that erythromycin may be more effective [68, 69] , intramuscular penicillin should be used if the patient's compliance is in doubt. Because neither regimen is 100% effective [67, 69] and bacteriologic relapse is possible [64] , specimens from carriers should be cultured a minimum of 2 weeks after the completion of therapy to ensure that the organism has been eradicated [64, 70] .
Vaccination of Contacts
The vaccination status of all persons exposed to diphtheria should be assessed, and diphtheria toxoid should be administered according to the algorithm shown in figure 1 . The rapid increase in diphtheria antitoxin expected with booster immunization [71, 72] is theoretically protective against the effects of diphtheria toxin.
Contacts of Carriers
On the basis of historical studies of diphtheria transmission. Doull and Lara estimated that the risk of developing diphtheria is sevenfold higher after household exposure to an individual with clinical diphtheria than after household exposure to a carrier (2.1% and 0.3%, respectively) [62] . Local destruction of tissue at the site of membrane formation in clinical diphtheria is thought to promote bacterial multiplication, which, in turn, enhances transmission [16, 17] . Thus, close contacts of persons with clinical diphtheria must be assigned the highest priority for preventive measures. Contacts of carriers should be given secondary priority. Moreover, prompt administration of antimicrobial prophylaxis to all persons exposed to diphtheria should reduce the likelihood of transmission by carriers. The benefits of excluding carriers from school or work may be minimal if their identification is delayed.
Routine Community-Wide Vaccination
The most important measure for preventing diphtheria is an ongoing community-wide program of active immunization that emphasizes on-time vaccination of children and booster immunization of adults. After completion of a primary series of diphtheria toxoid injections, all persons should receive a booster dose every 10 years [46, 50] . Combined diphtheria and tetanus toxoids should be given whenever the use of tetanus toxoid is indicated (e.g., for wound management) [46, 50] .
Summary
Our investigation illustrates the potentially devastating consequences of the introduction of toxigenic C. diphtheriae into a community and emphasizes the need for a high index of suspicion regarding diphtheria, especially in inadequately vaccinated patients. Maintenance of a high level of clinical awareness of diphtheria, prompt investigation of sporadic cases with systematic identification and management of close contacts, and improvement of vaccination levels in the community are needed to prevent further morbidity and mortality due to diphtheria. In view of the continued occurrence of diphtheria in developing countries and the frequency of international travel in the current era, such measures will be necessary if the United States is to achieve its goal of eliminating diphtheria among persons ≤25 years of age by the year 2000. The ultimate goal will be to eliminate this disease among persons of all ages.
